Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner
R. Madsen, R. Knox, W. Pearce, S. Lopez, B. Mahler-Araujo, N. McGranahan, B. Vanhaesebroeck, R. Semple
This study shows that homozygous PIK3CAH1047R mutations in iPSCs lead to cancer-like changes, while heterozygous mutations do not, highlighting allele dose-dependent effects.
bioRxiv · Dec 13, 2018Cancer Biology